|
Post by iamaverb on Jan 21, 2015 20:53:25 GMT
Looks like I just saved close to 30% in losses today by selling early. Looks like I should have sold the other 20%, even is those would have been short term sales.
|
|
|
Post by JHam on Jan 27, 2015 16:35:13 GMT
|
|
|
Post by JHam on Feb 18, 2015 18:07:16 GMT
|
|
|
Post by JHam on Feb 18, 2015 18:16:40 GMT
Jeezus, institutions cannot get enough of their Advaxis. Too bad for those market conditions...:
Advaxis Completes $23 Million Financing
PRINCETON, N.J., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, announced that it has executed definitive securities purchase agreements with several institutional investors for gross proceeds of approximately $23.0 million in a registered direct offering of approximately 3.1 million shares at a price of $7.50 per share. The pricing on this transaction reflects the at-the-market closing price on February 17, 2015.
Adage Capital Management, L.P. ("Adage"), Broadfin Capital LLC, Sectoral Asset Management, Cormorant Asset Management and certain funds and accounts managed by T. Rowe Price Associates, Inc. participated in this financing along with another institutional investor. Following the close of the transaction, Adage will own approximately 19% of the outstanding shares of Advaxis. Proceeds from this financing will be used primarily to fund the continued clinical development of Advaxis's cancer immunotherapy pipeline.
|
|
|
Post by iamaverb on Mar 5, 2015 20:09:11 GMT
Jeezus, institutions cannot get enough of their Advaxis. Too bad for those market conditions...: Advaxis Completes $23 Million Financing PRINCETON, N.J., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, announced that it has executed definitive securities purchase agreements with several institutional investors for gross proceeds of approximately $23.0 million in a registered direct offering of approximately 3.1 million shares at a price of $7.50 per share. The pricing on this transaction reflects the at-the-market closing price on February 17, 2015.Adage Capital Management, L.P. ("Adage"), Broadfin Capital LLC, Sectoral Asset Management, Cormorant Asset Management and certain funds and accounts managed by T. Rowe Price Associates, Inc. participated in this financing along with another institutional investor. Following the close of the transaction, Adage will own approximately 19% of the outstanding shares of Advaxis. Proceeds from this financing will be used primarily to fund the continued clinical development of Advaxis's cancer immunotherapy pipeline. It took less than a day to fill the order, and amazingly closed at $8.59 the following day. That tells you something I have been riding, buying, selling and re- buying this stock under 10 since the 3's and hold a sizeable position. Today I am up just over 50%. I have a 10% stop in place but I anticipate I won't be needing it at these levels. ADXS is garnering a lot of attention from a lot of the big boys.
|
|
|
Post by natureeguy on Mar 6, 2015 20:04:39 GMT
Congratulations. I don't have the guts to do that with this one. Thanks to JCK I've owned this since the 2's and been buying all along. This has to be the biggest gainer on the site, no? If this comes out with some news of a deal, trials starting, results, this thing is going to continue to fly, imho. Wish we had more banter about this one. Hope lots of folks on this board own this one...
|
|
|
Post by terrible on Mar 7, 2015 1:58:38 GMT
Nature...I've been in this one for quite awhile and it's my largest holding averaged @ 4.70. I took the ride to $13+ back down to $7 and now back to $12. I don't plan on selling or trading anytime soon. I believe with the low float and high institution holding the SP will continue to appreciate until it has a billion plus market cap (approx. $33 sp) in the next 12 months. Although I'm not a bog poster, I too wish there were more conversation here. It certainly has been an exciting ride and will continue IMO.
|
|
|
Post by JHam on Mar 7, 2015 8:55:59 GMT
Nature...I've been in this one for quite awhile and it's my largest holding averaged @ 4.70. I took the ride to $13+ back down to $7 and now back to $12. I don't plan on selling or trading anytime soon. I believe with the low float and high institution holding the SP will continue to appreciate until it has a billion plus market cap (approx. $33 sp) in the next 12 months. Although I'm not a bog poster, I too wish there were more conversation here. It certainly has been an exciting ride and will continue IMO. Great job guys on your low cost averages. There is a lot to like about this stock. I would like to own this one, but I am scared to buy right now after such a huge rally. That said, the market cap is still very low compared to some other companies making noise in the sector (ZIOP for example is over $1.5B) and as long as ADXS can continue to produce positive data, I imagine it will continue to climb. I think the reason why there isn't more discussion here is because some of us feel like it has already left the station. As I said above I think there is certainly more room to grow, but there are other stocks that some of us are holding, that we are hoping will be the next ADXS. I am still very interested in this one and am keeping my eye on it. I had a very nice profit from this one 2 years ago. Good luck you guys!
|
|
|
Post by natureeguy on Mar 7, 2015 11:49:45 GMT
Hi Jham,
Thanks for the well wishes. I held ocat for over 7 years before finally selling it and putting it all in adxs. Owe a lot to Jck, and of course this board. Can't thank you enough for putting it together.
I think adxs has really turned into a real company and has some room to run still. Wouldn't be surprised to see the 20's this year. This stock is really changing my financial life. Perhaps I paid my dues with ocat for all those years. Anyway I am extremely grateful. I am actually able to help my sons out with college now...great feeling. Thanks Jck! You might be right about why folks aren't talking about this. But could you imagine if ocat went from the 2's to 12 in a few months...that message board would be going crazy. In light of your comment about some other companies on the doorstep of making some adxs like moves... can you share some of your favorites? Thanks and enjoy the weekend.
|
|
|
Post by jckrdu on Mar 7, 2015 13:03:14 GMT
Hi Jham, Thanks for the well wishes. I held ocat for over 7 years before finally selling it and putting it all in adxs. Owe a lot to Jck, and of course this board. Can't thank you enough for putting it together. I think adxs has really turned into a real company and has some room to run still. Wouldn't be surprised to see the 20's this year. This stock is really changing my financial life. Perhaps I paid my dues with ocat for all those years. Anyway I am extremely grateful. I am actually able to help my sons out with college now...great feeling. Thanks Jck! You might be right about why folks aren't talking about this. But could you imagine if ocat went from the 2's to 12 in a few months...that message board would be going crazy. In light of your comment about some other companies on the doorstep of making some adxs like moves... can you share some of your favorites? Thanks and enjoy the weekend. Hey Nature,
Glad to hear ADXS has worked out for you. Hearing its changed your financial life makes my day. I still follow ADXS, but not as closely. I almost bought back in with a position after that recent hatchet job article took it down to the $7s, as I figured there'd be a recovery. Some thoughts....
On ADXS - I agree with JHam that it certainly can run more, but at a $280 million market cap, I'm not sure how much more upside there is in the near-term. My sense is that results from the combination trials with Merck and Astra will need to be released and show positive efficacy before the market is going to assign a $500 million or $1B market cap. The low float and institutional interest are definitely working in ADXS favor, but that said another big move - in the nearterm - may not be in the cards. What else besides Phase 2-combo trial results could drive it higher in the near-term? Well, the licensing deal with Aratana may start bearing fruit (milestone payments & revenue) sometime this year... but the wildcard IMO is the possibility to commercialize in India with Biocon based on the Phase 2 results. I haven't seen any news on that front. IF ADXS announces that they're able to go to market in India without running a Phase 3 trial, that'd be a huge catalyst IMO. On the otherhand, if they announce that a Phase 3 trial is needed (ADXS would have to pay the costs of that trial) that could let a little air out of the balloon. I think ADXS is a good longterm hold, but like JHam... I see some other opportunities that I like better in the nearterm... see below in response to your question on other stocks.
On ATHX - I'm concentrated here (also have a small position in CUR for ALS results which should be out next week). I built my position here in the $1.20s & $1.30s over the past 6 months or so in advance of stroke results which will be announced in April. See the ATHX board for more details. Very briefly, the pre-data run-up is still in process. If stroke results shows any efficacy (good chance it will IMO) the stock is going to move to the $7 to $10 range very quickly, and will likely keep running higher from there. IMO, skimming some off the top from ADXS and diversifying with a speculative position in ATHX could payoff.
Good luck!
jck
|
|
|
Post by natureeguy on Mar 7, 2015 13:24:15 GMT
Hey Jck, Great to hear from you. You do know you are my hero I agree with your thoughts about adxs. I think there might also be some wildcards in play. Some of the moves Dan has pulled off seemed to not only be unexpected but amazing, considering the shape of the company at the time. As I mentioned many months ago, I do have a lot of faith and respect for him. I think he is the real deal and has built up a ton of credibility for this company. We still are waiting for the Latin American deal that has been promised, which may not move the needle tremendously but you never know based on what it's all about. I also believe Dan is working on some other financing to build his money base for leverage in the future. It wouldn't surprise me to see more hires coming up, as well as announcements of additional clinical trials in the works. The combination of institutional investments the last 4 months, upcoming trials, the management/scientific team and this sector getting some major interest,,,, just think folks will start to get motivated to invest...even with the run up. I have followed you with athx. You seemed to have nailed it so far. Great advice about taking a little off the top and putting some in athx. Thanks again for your excellent thoughts and advice.
|
|
|
Post by terrible on Mar 10, 2015 1:04:38 GMT
Another big day for ADXS. I'm still planning on holding, but it's getting tough not to take some off the top. My plan is to wait until $20.00.
|
|
|
Post by JHam on Mar 10, 2015 2:26:36 GMT
Another big day for ADXS. I'm still planning on holding, but it's getting tough not to take some off the top. My plan is to wait until $20.00. Wow. That is gutsy. It would be hard for me to have a 100%+ profit and not take some off the table (not trying to tell you what to do). It could see $20, not sure if that will happen in the near future or not, but eventually this rally will start to fizzle out. At some point I imagine it will start to get shorted as well. It's just knowing at what point this happens. That is my big reason for not opening a position. Would be amazing for you if it makes it up to $20.
|
|
|
Post by terrible on Mar 10, 2015 11:56:18 GMT
I hear ya JHam. There may be a little exuberance in my post. I'll continue to evaluate and lock in some profits at some point. I do believe shorting this stock is becoming more of a risk as institutions continue to own more of the float. I think the SP could still explode on news.
|
|
|
Post by natureeguy on Mar 10, 2015 12:26:51 GMT
I think that's the interesting thing about this upward march. We are still waiting on what could be some significant news. I have complete faith that Dan is doing some amazing stuff behind the scenes. He has a ton of his own money invested, as well as the other management players. I know there will be some pullbacks but wont be surprised if this hits 20 by end of summer. I am so curious about what this Latin American deal is all about....
|
|
|
Post by terrible on Mar 10, 2015 12:38:39 GMT
Agreed nature. News could hit at anytime on a number of fronts including the go ahead in India. Should be an exciting spring/summer.
|
|
|
Post by terrible on Mar 10, 2015 12:43:51 GMT
One additional thought on DOC. Although he ticked off a lot of investors with the share grab early on, he has certainly executed on the plan that he laid out and has hit every deadline put forth. I truly believe that makes a difference and builds confidence with investors.
|
|
|
Post by actcfan on Mar 10, 2015 17:58:56 GMT
Thanks for the thoughts here all. I went ahead and locked in 50% profit on this one for now. I'd potentially get back in if it floats down again
|
|
|
Post by JHam on Mar 10, 2015 18:37:15 GMT
Thanks for the thoughts here all. I went ahead and locked in 50% profit on this one for now. I'd potentially get back in if it floats down again Well done!
|
|
|
Post by iamaverb on Mar 16, 2015 15:52:38 GMT
Last Tuesday I hit my stops and was forced out of ADXS for a hefty profit as the stock fell 10%, and had to re-enter later the same day for a 7% haircut. I had my doubts about getting back in after that days volatility, but not anymore. After today's announcement I look forward to a potential bidding war for the purchase of the company. Advaxis partnered early and often, and not for very much money. Just enough money, but not very much, but enough to garner market attention and able to keep the trials continuing.
|
|